Detalhe da pesquisa
1.
Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial.
Diabetes Obes Metab
; 18(2): 186-90, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26443993
2.
Impact of treatment with saxagliptin on glycaemic stability and ß-cell function in the SAVOR-TIMI 53 study.
Diabetes Obes Metab
; 17(5): 487-94, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25656169
3.
Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?
Eur Heart J
; 40(18): 1466-1471, 2019 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29945212
4.
Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.
Int J Obes (Lond)
; 38(3): 364-70, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24166065
5.
Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
Diabetes Obes Metab
; 16(12): 1230-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25132119
6.
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial.
Diabetes Metab Res Rev
; 29(5): 417-26, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23564755
7.
Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease.
Eur J Vasc Endovasc Surg
; 43(2): 198-207, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22001145
8.
Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial.
Circulation
; 132(15): e198, 2015 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26459088
9.
Predicting 10-year risk of recurrent cardiovascular events andcardiovascular interventions in patients with established cardiovascular disease: results from UCC-SMART and REACH.
Int J Cardiol
; 325: 140-148, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32987048
10.
Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease.
J Intern Med
; 267(6): 621-33, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20210837
11.
Economic implications of obesity among people with atherothrombotic disease.
Int J Obes (Lond)
; 34(8): 1284-92, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20195286
12.
Response to: 'Baseline differences in SAVOR trial'-- prespecified vs. post hoc analysis--a potential source of bias.
Diabetes Obes Metab
; 17(12): 1203-4, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26419822
13.
Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
Eur J Vasc Endovasc Surg
; 40(1): 9-16, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20385507
14.
Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry.
Ann Cardiol Angeiol (Paris)
; 69(4): 158-166, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32778388
15.
High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH Registry.
Eur J Neurol
; 16(8): 902-8, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19473362
16.
Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery.
Circulation
; 103(3): 363-8, 2001 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-11157686
17.
Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention.
Circulation
; 104(9): 992-7, 2001 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-11524391
18.
Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.
Circulation
; 103(7): 961-6, 2001 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-11181470
19.
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions.
Circulation
; 102(1): 28-34, 2000 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-10880411
20.
Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators.
Circulation
; 102(24): 2952-8, 2000 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-11113045